VBI-S

· Vivacelle Bio

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VBI-S, covering 2023-10-23 to 2025-04-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02) [Phase 3]

See pricing